NASDAQ · Biotechnology

NLS Pharmaceutics AG (NLSP) Stock

$2.91 -12.61% NASDAQ: NLSP Healthcare

NLS Pharmaceutics AG is a biopharmaceutical firm dedicated to researching and creating treatments for intricate and uncommon conditions affecting the central nervous system. Its primary focus includes advancing medications for narcolepsy, idiopathic hypersomnia, and various other unusual sleep conditions, alongside neurodevelopmental challenges like attention deficit hyperactivity disorder (ADHD).

Valuation

MetricValue
Price$2.91
Market Cap$919601
P/E Ratio-0.43
P/B Ratio1.86
P/S Ratio0.00
EPS (TTM)$-26.30
52-Week High$43.40
52-Week Low$0.76
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE41.94%
ROA18.57%
ROCE-81.09%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.05
Current Ratio0.76

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-12.0M$-15.0M$-12.0M$-4.0M
Net Profit$-3.0M$-12.0M$-16.0M$-12.0M$-2.0M
EPS$-5.90$-8.10$-8.40$-3.20$-26.30
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$1.0M$6.0M$9.0M$2.0M$2.0M
Total Liabilities$10.0M$5.0M$6.0M$11.0M$1.0M
Cash$0$5.0M$9.0M$1.0M$2.0M
Borrowings$2.0M$0$0$2.0M$0

Latest News

Venezuela transition talks to start in person next week: govt AFP · Aug 1, 2026 Why Aug. 4 Could Be a Big Day for the Stock Market Motley Fool · Aug 1, 2026 Here’s What AfroTech Saw At The First AI Edge Workshop AfroTech · Aug 1, 2026 Coldcard hack just grew to $75M, call your friends TheStreet · Aug 1, 2026 Why IMAX Stock Keeps Rising Motley Fool · Aug 1, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-1.0M$-15.0M$-14.0M$-10.0M$-4.0M
Investing Cash Flow$0$0$-4.0M$0$0
Financing Cash Flow$-1.0M$8.0M$7.0M$0$0
Net Cash Flow$0$5.0M$4.0M$-8.0M$1.0M
Free Cash Flow$-1.0M$-15.0M$-14.0M$-10.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA0.01
FCF Yield-115.32%
Quick Ratio0.76
Interest Coverage-15269.76
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BACKIMAC Holdings, Inc. $0.02 +0.00% -0.01 $79484 0.00%
BCTXWBriaCell Therapeutics Corp. $0.00 — 0.00 $1695 0.00%
CELUCelularity Inc. $0.75 +0.13% -0.20 $21.74M 0.00%
CEROCERo Therapeutics Holdings, Inc. $0.01 -7.69% 0.00 $14464 0.00%
KTTA $0.45 -2.17% -0.25 $3.35M 0.00%

About NLS Pharmaceutics AG

NLS Pharmaceutics AG is a biopharmaceutical firm dedicated to researching and creating treatments for intricate and uncommon conditions affecting the central nervous system. Its primary focus includes advancing medications for narcolepsy, idiopathic hypersomnia, and various other unusual sleep conditions, alongside neurodevelopmental challenges like attention deficit hyperactivity disorder (ADHD). Key experimental compounds in its pipeline are Quilience, designed to address excessive daytime sleepiness and cataplexy, and Nolazol, which targets ADHD. Established in 2015, the company maintains its headquarters in Zurich, Switzerland.

NLS Pharmaceutics AG is headquartered in CH.

NLS Pharmaceutics AG (NLSP) stock trades at $2.91 with a market capitalization of $919601. The stock is valued at a price-to-earnings (P/E) ratio of -0.43, price-to-book of 1.86, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.76 and $43.40, and currently trades 93.3% below its 52-week high.

On profitability, NLS Pharmaceutics AG generates a return on equity (ROE) of 41.94% — well above the market average, a sign of a high-quality business, return on capital employed of -81.09%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: nlspharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides